Tateishi R - Search Results

1

Clinical features of patients with HCC who are negative for both HBV and HCV markers.

Watabe H, Shiratori Y, Tateishi R, Fujishima T, Akamatsu M, Koike Y, Obi S, Hamamura K, Sato S, Teratani T, Shiina S, Omata M. Watabe H, et al. Among authors: tateishi r. Hepatogastroenterology. 2003 Nov-Dec;50(54):2157-60. Hepatogastroenterology. 2003. PMID: 14696486

2

Factors predisposing to poorly differentiated hepatocellular carcinoma and its recurrence.

Akamatsu M, Ishikawa T, Shiratori Y, Koike Y, Shiina S, Teratani T, Hamamura K, Obi S, Sato S, Tateishi R, Fujishima T, Imai Y, Yoshida H, Omata M. Akamatsu M, et al. Among authors: tateishi r. Hepatogastroenterology. 2005 Mar-Apr;52(62):391-7. Hepatogastroenterology. 2005. PMID: 15816443

3

Sustained viral response prolonged survival of patients with C-viral hepatocellular carcinoma.

Akamatsu M, Yoshida H, Shiina S, Teratani T, Obi S, Tateishi R, Mine N, Kondo Y, Kawabe T, Omata M. Akamatsu M, et al. Among authors: tateishi r. Liver Int. 2006 Jun;26(5):536-42. doi: 10.1111/j.1478-3231.2006.01260.x. Liver Int. 2006. PMID: 16761997

4

APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024.

Lau G, Obi S, Zhou J, Tateishi R, Qin S, Zhao H, Otsuka M, Ogasawara S, George J, Chow PKH, Cai J, Shiina S, Kato N, Yokosuka O, Oura K, Yau T, Chan SL, Kuang M, Ueno Y, Chen M, Cheng AL, Cheng G, Chuang WL, Baatarkhuu O, Bi F, Dan YY, Gani RA, Tanaka A, Jafri W, Jia JD, Kao JH, Hasegawa K, Lau P, Lee JM, Liang J, Liu Z, Lu Y, Pan H, Payawal DA, Rahman S, Seong J, Shen F, Shiha G, Song T, Sun HC, Masaki T, Sirachainan E, Wei L, Yang JM, Sallano JD, Zhang Y, Tanwandee T, Dokmeci A, Zheng SS, Fan J, Fan ST, Sarin SK, Omata M. Lau G, et al. Among authors: tateishi r. Hepatol Int. 2024 Nov 21. doi: 10.1007/s12072-024-10732-z. Online ahead of print. Hepatol Int. 2024. PMID: 39570557

5

Surgically treated purulent pericarditis induced by ingested fish bone: a case report.

Itoda Y, Fukushima T, Kawamoto S, Shimozawa M, Tateishi R, Haba F, Ono S, Nakahara Y, Kanemura T. Itoda Y, et al. Among authors: tateishi r. Gen Thorac Cardiovasc Surg Cases. 2023 Nov 16;2(1):95. doi: 10.1186/s44215-023-00113-7. Gen Thorac Cardiovasc Surg Cases. 2023. PMID: 39517018 Free PMC article.

6

Factors involved in gastroesophageal varix-related events in patients with hepatitis C virus-related compensated and decompensated cirrhosis after direct-acting antiviral therapy.

Tahata Y, Hikita H, Mochida S, Enomoto N, Kawada N, Ido A, Miki D, Kurosaki M, Yoshiji H, Sakamori R, Kuroda H, Yatsuhashi H, Yamashita T, Hiasa Y, Kato N, Miyaaki H, Ueno Y, Itoh Y, Matsuura K, Takami T, Asahina Y, Suda G, Akuta N, Tateishi R, Nakamoto Y, Kakazu E, Terai S, Shimizu M, Miyazaki M, Nozaki Y, Sobue S, Yano H, Miyaki T, Moriuchi A, Hori T, Shirai K, Murai K, Saito Y, Kodama T, Tatsumi T, Yamada T, Takehara T. Tahata Y, et al. Among authors: tateishi r. Hepatol Res. 2024 Oct 29. doi: 10.1111/hepr.14131. Online ahead of print. Hepatol Res. 2024. PMID: 39470448

7

Machine Learning-Based Clustering Using a 12-Lead Electrocardiogram in Patients With a Implantable Cardioverter Defibrillator to Identify Future Ventricular Arrhythmia.

Tateishi R, Shimizu M, Suzuki M, Sakai E, Shimizu A, Shimada H, Katoh N, Nishizaki M, Sasano T. Tateishi R, et al. Circ J. 2024 Oct 1. doi: 10.1253/circj.CJ-24-0269. Online ahead of print. Circ J. 2024. PMID: 39358305 Free article.

8

[Treatment of hepatocellular carcinoma and risk of decompensation and liver failure].

Minami T, Tateishi R, Fujishiro M. Minami T, et al. Among authors: tateishi r. Nihon Shokakibyo Gakkai Zasshi. 2024;121(9):723-728. doi: 10.11405/nisshoshi.121.723. Nihon Shokakibyo Gakkai Zasshi. 2024. PMID: 39261052 Japanese. No abstract available.

9

[Unmet needs in hepatocellular carcinoma treatment - toward revision of clinical practice guidelines for hepatocellular carcinoma].

Tateishi R. Tateishi R. Nihon Shokakibyo Gakkai Zasshi. 2024;121(9):713-716. doi: 10.11405/nisshoshi.121.713. Nihon Shokakibyo Gakkai Zasshi. 2024. PMID: 39261050 Japanese. No abstract available.

10

Reply to: "Validation of SMART model for HCC risk stratification in genotype-4 HCV patients following SVR and its comparison with GES score".

Minami T, Fujishiro M, Tateishi R. Minami T, et al. Among authors: tateishi r. J Hepatol. 2024 Nov;81(5):e226-e227. doi: 10.1016/j.jhep.2024.07.005. Epub 2024 Jul 9. J Hepatol. 2024. PMID: 38992770 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

405 results

Search Page

Filters